Results for tag: "Irritable Bowel Syndrome With Constipation Drug"

The Irritable Bowel Syndrome with Constipation (IBS-C) Drug market is a subset of the Gastrointestinal Drugs market. It is composed of drugs used to treat IBS-C, a chronic disorder characterized by abdominal pain, bloating, and constipation. These drugs are typically prescribed to reduce symptoms and improve quality of life. Commonly used drugs include antispasmodics, laxatives, and serotonin-reuptake inhibitors. The IBS-C Drug market is highly competitive, with many companies offering products to treat the condition. Some of the major players in the market include Allergan, AstraZeneca, GlaxoSmithKline, Ironwood Pharmaceuticals, Novartis, and Shire. Other companies, such as AbbVie, Daiichi Sankyo, and Takeda, are also active in the market. Show Less Read more